Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases

References

• KelseyCRMarksLBHollisDLocal recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patientsCancer2009115225218522719672942
   PubMed Web of Science ®Google Scholar
• al-KattanKSepsasEFountainSWTownsendERDisease recurrence after resection for stage I lung cancerEur J Cardiothorac Surg19971233803849332915
   PubMed Web of Science ®Google Scholar
• MartiniNBainsMSBurtMEIncidence of local recurrence and second primary tumors in resected stage I lung cancerJ Thorac Cardiovasc Surg199510911201297815787
   PubMed Web of Science ®Google Scholar
• MartinJGinsbergRJVenkatramanESLong-term results of combined-modality therapy in resectable non-small-cell lung cancerJ Clin Oncol20022081989199511956257
   PubMed Web of Science ®Google Scholar
• DziedzicDARudzinskiPLangfortROrlowskiTPolish Lung Cancer Study Group (PLCSG)Risk factors for local and distant recurrence after surgical treatment in patients with non-small-cell lung cancerClin Lung Cancer2016175e157e16726831834
   PubMed Web of Science ®Google Scholar
• PfannschmidtJEditorial on “Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is ‘cured’ from postoperative recurrence?”J Thorac Dis201810261061329607121
   PubMed Web of Science ®Google Scholar
• TorokJAGuLTandbergDJPatterns of distant metastases after surgical management of non-small-cell lung cancerClin Lung Cancer2017181e57e7027477488
   PubMed Web of Science ®Google Scholar
• HellmanSWeichselbaumRROligometastasesJ Clin Oncol19951318107799047
   PubMed Web of Science ®Google Scholar
• GomezDRBlumenscheinGRLeeJJLocal consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyLancet Oncol201617121672168227789196
   PubMed Web of Science ®Google Scholar
• NakamuraMHashimotoNMayaharaHAdditional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrenceRadiat Oncol20181317529688858
   PubMedGoogle Scholar
• BaeSHAhnYCNamHHigh dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancerYonsei Med J20125361120112723074111
   PubMed Web of Science ®Google Scholar
• SekineINokiharaHYamamotoNKunitohHOheYTamuraTComparative chemotherapeutic efficacy in non-small cell lung cancer patients with postoperative recurrence and stage IV diseaseJ Thorac Oncol20094451852119347981
   PubMed Web of Science ®Google Scholar
• ShimadaYSajiHKakihanaMKajiwaraNOhiraTIkedaNSurvival outcomes for oligometastasis in resected non-small cell lung cancerAsian Cardiovasc Thorac Ann201523893794426207006
   PubMedGoogle Scholar
• NiibeYNishimuraTInoueTOligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjectsBMC Cancer201616165927542716
   PubMedGoogle Scholar
• De WolfJBellierJLepimpec-BarthesFExhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre studyEur J Cardiothorac Surg201752469870329156014
   PubMed Web of Science ®Google Scholar
• YamashitaHNiibeYYamamotoTLung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligo-metastasesJpn J Clin Oncol201646768769127162324
   PubMed Web of Science ®Google Scholar
• HishidaTYoshidaJAokageKNagaiKTsuboiMPostoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survivalEur J Cardiothorac Surg201649384785326201958
   PubMed Web of Science ®Google Scholar
• KelseyCRCloughRWMarksLBLocal recurrence following initial resection of NSCLC: salvage is possible with radiation therapyCancer J200612428328816925972
   PubMed Web of Science ®Google Scholar
• SekiharaKHishidaTYoshidaJLong-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence?Eur J Cardiothorac Surg201752352252828482033
   PubMed Web of Science ®Google Scholar
• YanoTOkamotoTHaroALocal treatment of oligometastatic recurrence in patients with resected non-small cell lung cancerLung Cancer201382343143524113550
   PubMed Web of Science ®Google Scholar
• WeichselbaumRRHellmanSOligometastases revisitedNat Rev Clin Oncol20118637838221423255
   PubMed Web of Science ®Google Scholar
• YanoTHaroAYoshidaTPrognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancerJ Surg Oncol2010102785285520886558
   PubMed Web of Science ®Google Scholar
• HowellGMCartySEArmstrongMJOutcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasisAnn Surg Oncol201320113491349623793361
   PubMed Web of Science ®Google Scholar
• AshworthABSenanSPalmaDAAn individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancerClin Lung Cancer201415534635524894943
   PubMed Web of Science ®Google Scholar
• WalshGLO’ConnorMWillisKMIs follow-up of lung cancer patients after resection medically indicated and cost-effective?Ann Thorac Surg1995606156315708787445
   PubMed Web of Science ®Google Scholar
• WongACWatsonSPPitrodaSPClinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)Cancer2016122142242225027206146
   PubMed Web of Science ®Google Scholar
• IgnatiadisMLeeMJeffreySSCirculating tumor cells and circulating tumor DNA: Challenges and opportunities on the path to clinical utilityClin Cancer Res201521214786480026527805
   PubMed Web of Science ®Google Scholar
• GaronEBRizviNAHuiRKEYNOTE-001 InvestigatorsPembrolizumab for the treatment of non-small-cell lung cancerN Engl J Med2015372212018202825891174
   PubMed Web of Science ®Google Scholar
• BrahmerJReckampKLBaasPNivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancerN Engl J Med2015373212313526028407
   PubMed Web of Science ®Google Scholar
• BorghaeiHPaz-AresLHornLNivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancerN Engl J Med2015373171627163926412456
   PubMed Web of Science ®Google Scholar
• BristowRGAlexanderBBaumannMCombining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation OncologyLancet Oncol2018195e240e25129726389
   PubMed Web of Science ®Google Scholar